Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about disclosure

15 Dec 2022 Evaluate
Aurobindo Pharma has informed that the Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 14, 2022 for RPR Sons, P Suneela Rani.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1812.00
Dr. Reddys Labs. 1360.00
Cipla 1373.90
Lupin 2017.50
Zydus Lifesciences 1244.95
View more..